Grant: ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing (Advanced Research and Invention Agency (ARIA) → University of Birmingham)
1 → partial; stale (excluded): 1 → partial
Our claim
entire record- Grantee
- University of Birmingham
- Name
- ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing
- Currency
- GBP
- Date
- January 2024
- Notes
- [Safeguarded AI TA3] Safeguarded AI-Enabled Biopharmaceutical Manufacturing. Lead(s): Mirco Giacobbe, Leonardo Stella, Paul Devine, Jared Delmar. Institutions: University of Birmingham / AstraZeneca. Status: active.
Source evidence
1 src · 2 checks- Grantee
- Hashberg Ltd / University of Birmingham
- Focus Area
- TA1.1
- Name
- Hyper-optimised Tensor Contraction for Neural Networks Verification
- Description
- Hashberg Ltd / University of Birmin
NotePartial deterministic match: grantee matched but name did not (48 rows)
NoteThe record claims a grant titled 'ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing' dated 2024-01. The source confirms TA3 exists within Safeguarded AI, but the source text explicitly states the programme is 'pivoting' away from TA3 Phase 2 and that current TA3 Phase 1 projects will continue. The source does not mention 'biopharmaceutical manufacturing' specifically as a TA3 focus. The source also does not provide the specific grant identifiers (XqjV4mbMXQ, bEVAImWDe3) or confirm a January 2024 date for this specific grant. The record appears to reference a specific grant that is not detailed in this source excerpt.